Interview with Harry Flore, CEO, HAL Allergy Group
Our meetings frequently bring us here to the Leiden Bio Science Park, but more often than not, to meet with younger, up-and-coming companies. HAL Allergy, meanwhile, has a rich and…
Address: Bijster 14
4817 HX Breda
Nederland
Tel: +31 (0)85 111 96 00
Web: http://www.cslbehring.nl/home
CSL Behring is a global leader in the plasma protein biotherapeutics industry. We research, develop, manufacture and market biotherapies that are used to treat serious and rare conditions. Users of our therapies rely on them for their quality of life and, in many cases, for life itself.
Our commitment to saving lives and improving the quality of life for people with serious and rare conditions is evident in everything we do. Whether we are manufacturing and marketing safe and effective products or researching and developing innovative biotherapies, we are first and foremost focused on fulfilling our customers’ needs.
CSL Behring is a specialty biotherapeutics company, serving people with rare and serious diseases around the globe for more than a century.
Biotherapies differ from conventional pharmaceuticals in that they treat diseases with products derived from human plasma or manufactured by recombinant technologies, while conventional pharmaceuticals derive their products from chemicals. Biotherapeutic proteins replace missing components in the blood.
CSL Behring develops, manufactures, and markets protein-based therapies in the Bleeding Disorders, Critical Care, Immunoglobulins, Pulmonary, and Wound Healing areas.
Our meetings frequently bring us here to the Leiden Bio Science Park, but more often than not, to meet with younger, up-and-coming companies. HAL Allergy, meanwhile, has a rich and…
You are still relatively new to the Netherlands having been here for one year. This must be a very insightful experience abroad. What were your initial expectations and first impressions…
You began as managing director of this Dutch affiliate close to one year ago. What was the trajectory that led you to this position and what were your initial impressions…
Since its founding Galapagos has operated with a hybrid business model which has combined its internal discoveries with service activities. This model has worked quite well as it has now…
As much as this report is about business trends and insights, we also like to portray the personalities of the industry in the markets that we cover. What has been…
Shire has many offices in America, Europe, as well as in Singapore, in Japan and in Australia. The group has a vast global network and a strong presence in these…
Promega is a truly global company with a vast international presence. What would you say is the strategic importance that the Benelux affiliate has assumed within Promega’s global network? Promega…
See our Cookie Privacy Policy Here
